Target intelligence / Profile preview

MYRF antisense RNA 1 (MYRF-AS1)

Target
MYRF-AS1
Molecular classification
Other (non-coding RNA, specifically long non-coding RNA/antisense RNA, not enzyme, receptor, transporter, or transcription factor)
01

Overview

MYRF antisense RNA 1 (MYRF-AS1, also known as DKFZP434K028) is an annotated long non-coding RNA and antisense RNA in the human genome. It is named for its location antisense to the MYRF (myelin regulatory factor) gene, but currently, no evidence indicates that MYRF-AS1 encodes a protein, functions as a receptor, enzyme, transporter, or serves as a therapeutic target. There is no published evidence of it exerting a regulatory role in disease, or any relevance as a drug target, biomarker, therapeutic mechanism, or safety concern. This distinguishes it from the unrelated MYRF-1 and related genes, which are transmembrane transcription factors involved in developmental processes—MYRF-AS1 specifically refers to the RNA molecule and not to any protein or receptor[1][2][3]. The entries in the provided search results refer extensively to MYRF-1, which is a transcription factor in *C. elegans*, but do not reference MYRF-AS1. MYRF-AS1 appears to be a misidentified or non-relevant research target for therapeutic development and lacks supporting evidence in the literature as a functional molecule. Thus, the entry is considered incorrect—it is not a protein, receptor, enzyme, known target, or even established as a functional non-coding RNA.

Other names
DKFZP434K028MYRF-AS1
02

Biological functions

Unknown (No evidence for a direct biological function; not a protein coding gene; listed as an antisense RNA)
03

Disease associations

Unknown (No evidence for disease association or therapeutic relevance)

Beyond the preview

Go deeper on MYRF antisense RNA 1 (MYRF-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MYRF antisense RNA 1 (MYRF-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call